2YRSlnnovita (Tangshan) Biological Technology Co., Ltd.

COMPANY OVERVIEW

Company Album3

Basic Information
Innovita Biological Technology Co., Ltd. (together with its subsidiaries, collectively known as "INNOVITA") is a biotechnology company specialized in R&D, manufacturing and marketing of in vitro diagnostic POCT products. It consists of INNOVITA (Beijing), INNOVITA (Tangshan) and INNOVITA (Guangzhou).Founded in 2006, INNOVITA has built six technical platforms such as antigen & antibody preparation, virus culture, colloidal gold, ELISA, fluorescence chromatography, PCR, and undertakes Chinese National High-tech R&D Program in the field of national major infectious diseases research and many other public health projects. Besides, INNOVITA has over ten national invention patents and set up Beijing R&D center, Guangzhou R&D center, Tangshan production base. With large clean workshops and production lines of colloidal gold, ELISA, fluorescence chromatography, PCR and immunofluorescence, INNOVITA has obtained FDA, CE, ISO13485, MDSAP certification.At present, INNOVITA products include respiratory diseases tests, fertility tests, hepatitis tests, TORCH tests, tropical diseases tests, gastrointestinal diseases tests, drug of abuse tests and so on. The sales network has covered all provinces and regions in China, and has been expanded to Southeast Asia, the Middle East, Africa, Latin America, the European Union, etc.
  • Transactions
    -
Business type
Manufacturer, Trading Company
Country / Region
Hebei, China
Main ProductsTotal employees
301 - 500 People
Total Annual Revenue
US$2.5 Million - US$5 Million
Year established
2011
Certifications
-
Product Certifications(1)
Patents
-
Trademarks
-
Main Markets

PRODUCT CAPACITY

Factory Information

Factory Size
50,000-100,000 square meters
Factory Country/Region
No. 699, Juxin Street, High-Tech Industry Development Zone, Qian'an, Tangshan City, Hebei Province, China
No. of Production Lines
Above 10
Contract Manufacturing
OEM Service Offered, Design Service Offered, Buyer Label Offered
Annual Output Value
US$50 Million - US$100 Million